CryoLife to purchase German firm Jotec for $225m

MDBR Staff Author Printed 11 October 2017

Medical tool and tissue processing company CryoLife has decided to acquire Germany-based Jotec for around $225m.

According to the deal, CryoLife pays 75% in cash, additionally to issuing 25% of their common stock to Jotec shareholders.

Located in Hechingen, Jotec is involved in the event, production and marketing of medical devices for aortic and peripheral vascular disease.

Their product portfolio includes conventional vascular grafts and interventional implants for vascular and cardiac surgery and radiology and cardiology.

Its products include thoracic stent grafts, abdominal stent grafts and peripheral stent grafts, in addition to interventional accessories.

Additionally, Jotec’s surgical portfolio includes ePTFE vascular grafts and polyester grafts.

 The acquisition allows CryoLife to grow its presence within the endovascular surgical market.

Susceptible to customary closing conditions, the offer is anticipated to accomplish later this season.

CryoLife president and Chief executive officer Pat Mackin stated: “Jotec includes a technologically differentiated product portfolio addressing the $2bn global marketplace for stent grafts utilized in endovascular and open repair of aortic illnesses.  

“Their advanced product portfolio has permitted these to acquire a 17% revenue CAGR in the last 5 years, considerably outpacing the development within the overall European market.”

Jotec Chief executive officer Thomas Bogenschütz stated: “CryoLife is ideally positioned to accelerate adoption in our products through its highly complementary and global cardiac and vascular surgery business.”

Located in suburban Atlanta of Georgia, CryoLife produces, processes and distributes medical devices and implantable living tissues utilized in cardiac and vascular surgical treatments.


Image: CryoLife to get Germany-based Jotec. Photo: thanks to adamr / FreeDigitalPhotos.internet.

The Ten most typical telemedicine program objectives

telehealth, telemedicine, physician, tablet, medicine

A brand new survey from Achieve Health unearthed the benefits and drawbacks of using a telehealth program.

Roughly 436 medical professionals, executives, nurses and physicians required part within the survey, that was conducted in December 2016 and The month of january 2017. 4 % of total participants were customers of Achieve Health, a telemedicine software company located in Atlanta, Georgia.

Nearly one-quarter of respondents (21 percent) indicated telemedicine is among their organization’s top priorities. 30 % stated it’s a higher priority, and 36 percent stated it’s a medium priority. Only 13 % consider telehealth a minimal priority in their organization.

Advertisement

Despite nearly all participants saying yes about this as being a key issue, they expressed a number of different causes of applying a telemedicine program.

Based on the survey, 10 most typical telemedicine program objectives are:

  • Improving patient outcomes
  • Growing patient engagement and gratification
  • Improving patient convenience
  • Supplying remote and rural patients with use of care
  • Improving leverage of limited physician sources
  • Reducing price of care delivery
  • Reducing hospital readmissions
  • Improving specialist efficiency
  • Supplying use of new specialties
  • Supplying 24/7 use of specialists

Other objectives incorporated reducing emergency department overcrowding, growing revenue and supporting research or numerous studies.

Nearly all participants (59 percent) stated their organization’s telehealth platform is mainly supplied by a vendor. Forty-3 % noted their platform is mainly put together internally using specialized components.

No matter are you going to from the build versus. buy debate they’re on, participants appeared to value numerous similar features inside a telemedicine platform.

A couple of of the very most crucial features are integrated video and audio for live patient engagement the opportunity to produce documentation from each encounter support for normal services and also the ability for clinicians to speak through HIPAA-compliant messaging.

However the journey to some effective telemedicine program isn’t simple. Respondents also addressed the down sides they face.

Top challenges include reimbursement (from Medicare, State medicaid programs and payers) and insufficient telemedicine parity laws and regulations. Survey participants also stated figuring out Return on investment, physician compensation and insufficient Electronic health record integration are problems.

Searching ahead, participants were requested the way they expect a possible repeal or substitute from the Affordable Care Act to affect their telehealth programs.

Thirty-3 % stated this kind of action would increase the value of telemedicine within their organization, and just 3 % noted it might decrease the amount of important telemedicine is. Another 38 percent felt the significance of telehealth would stay comparable, and 26 % stated they’re not able to predict the way it can change.

Photo: nito100, Getty Images